Molecular Diagnostic Instrument market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostic Instrument market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Molecular Diagnostic Instrument market is segmented into
Nucleic Acid Extractor
PCR Instrument
Nucleic Acid Molecule Hybridization Instrument
Gene Chip Instrument
Genetic Sequencer
Segment by Application, the Molecular Diagnostic Instrument market is segmented into
Hospital
Clinic
Laboratory
Regional and Country-level Analysis
The Molecular Diagnostic Instrument market is analysed and market size information is provided by regions (countries).
The key regions covered in the Molecular Diagnostic Instrument market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Molecular Diagnostic Instrument Market Share Analysis
Molecular Diagnostic Instrument market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Molecular Diagnostic Instrument by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Molecular Diagnostic Instrument business, the date to enter into the Molecular Diagnostic Instrument market, Molecular Diagnostic Instrument product introduction, recent developments, etc.
The major vendors covered:
Illumina
ThermoFisher
Roche
DAAN Gene
BGI Group
Agilent Technologies
QIAGEN
Macrogen
ELITech Group
Analytik Jena
Bio-Rad
Promega
1 Study Coverage
1.1 Molecular Diagnostic Instrument Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Molecular Diagnostic Instrument Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Molecular Diagnostic Instrument Market Size Growth Rate by Type
1.4.2 Nucleic Acid Extractor
1.4.3 PCR Instrument
1.4.4 Nucleic Acid Molecule Hybridization Instrument
1.4.5 Gene Chip Instrument
1.4.6 Genetic Sequencer
1.5 Market by Application
1.5.1 Global Molecular Diagnostic Instrument Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Laboratory
1.6 Coronavirus Disease 2019 (Covid-19): Molecular Diagnostic Instrument Industry Impact
1.6.1 How the Covid-19 is Affecting the Molecular Diagnostic Instrument Industry
1.6.1.1 Molecular Diagnostic Instrument Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Molecular Diagnostic Instrument Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Molecular Diagnostic Instrument Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Molecular Diagnostic Instrument Market Size Estimates and Forecasts
2.1.1 Global Molecular Diagnostic Instrument Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Molecular Diagnostic Instrument Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Molecular Diagnostic Instrument Production Estimates and Forecasts 2015-2026
2.2 Global Molecular Diagnostic Instrument Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Molecular Diagnostic Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Molecular Diagnostic Instrument Manufacturers Geographical Distribution
2.4 Key Trends for Molecular Diagnostic Instrument Markets & Products
2.5 Primary Interviews with Key Molecular Diagnostic Instrument Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Molecular Diagnostic Instrument Manufacturers by Production Capacity
3.1.1 Global Top Molecular Diagnostic Instrument Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Molecular Diagnostic Instrument Manufacturers by Production (2015-2020)
3.1.3 Global Top Molecular Diagnostic Instrument Manufacturers Market Share by Production
3.2 Global Top Molecular Diagnostic Instrument Manufacturers by Revenue
3.2.1 Global Top Molecular Diagnostic Instrument Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Molecular Diagnostic Instrument Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Molecular Diagnostic Instrument Revenue in 2019
3.3 Global Molecular Diagnostic Instrument Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostic Instrument Production by Regions
4.1 Global Molecular Diagnostic Instrument Historic Market Facts & Figures by Regions
4.1.1 Global Top Molecular Diagnostic Instrument Regions by Production (2015-2020)
4.1.2 Global Top Molecular Diagnostic Instrument Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Molecular Diagnostic Instrument Production (2015-2020)
4.2.2 North America Molecular Diagnostic Instrument Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Molecular Diagnostic Instrument Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Molecular Diagnostic Instrument Production (2015-2020)
4.3.2 Europe Molecular Diagnostic Instrument Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Molecular Diagnostic Instrument Import & Export (2015-2020)
4.4 China
4.4.1 China Molecular Diagnostic Instrument Production (2015-2020)
4.4.2 China Molecular Diagnostic Instrument Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Molecular Diagnostic Instrument Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Molecular Diagnostic Instrument Production (2015-2020)
4.5.2 Japan Molecular Diagnostic Instrument Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Molecular Diagnostic Instrument Import & Export (2015-2020)
5 Molecular Diagnostic Instrument Consumption by Region
5.1 Global Top Molecular Diagnostic Instrument Regions by Consumption
5.1.1 Global Top Molecular Diagnostic Instrument Regions by Consumption (2015-2020)
5.1.2 Global Top Molecular Diagnostic Instrument Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Molecular Diagnostic Instrument Consumption by Application
5.2.2 North America Molecular Diagnostic Instrument Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Molecular Diagnostic Instrument Consumption by Application
5.3.2 Europe Molecular Diagnostic Instrument Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Molecular Diagnostic Instrument Consumption by Application
5.4.2 Asia Pacific Molecular Diagnostic Instrument Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Molecular Diagnostic Instrument Consumption by Application
5.5.2 Central & South America Molecular Diagnostic Instrument Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Molecular Diagnostic Instrument Consumption by Application
5.6.2 Middle East and Africa Molecular Diagnostic Instrument Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Molecular Diagnostic Instrument Market Size by Type (2015-2020)
6.1.1 Global Molecular Diagnostic Instrument Production by Type (2015-2020)
6.1.2 Global Molecular Diagnostic Instrument Revenue by Type (2015-2020)
6.1.3 Molecular Diagnostic Instrument Price by Type (2015-2020)
6.2 Global Molecular Diagnostic Instrument Market Forecast by Type (2021-2026)
6.2.1 Global Molecular Diagnostic Instrument Production Forecast by Type (2021-2026)
6.2.2 Global Molecular Diagnostic Instrument Revenue Forecast by Type (2021-2026)
6.2.3 Global Molecular Diagnostic Instrument Price Forecast by Type (2021-2026)
6.3 Global Molecular Diagnostic Instrument Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Molecular Diagnostic Instrument Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Molecular Diagnostic Instrument Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 Illumina
8.1.1 Illumina Corporation Information
8.1.2 Illumina Overview and Its Total Revenue
8.1.3 Illumina Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Illumina Product Description
8.1.5 Illumina Recent Development
8.2 ThermoFisher
8.2.1 ThermoFisher Corporation Information
8.2.2 ThermoFisher Overview and Its Total Revenue
8.2.3 ThermoFisher Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 ThermoFisher Product Description
8.2.5 ThermoFisher Recent Development
8.3 Roche
8.3.1 Roche Corporation Information
8.3.2 Roche Overview and Its Total Revenue
8.3.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Roche Product Description
8.3.5 Roche Recent Development
8.4 DAAN Gene
8.4.1 DAAN Gene Corporation Information
8.4.2 DAAN Gene Overview and Its Total Revenue
8.4.3 DAAN Gene Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 DAAN Gene Product Description
8.4.5 DAAN Gene Recent Development
8.5 BGI Group
8.5.1 BGI Group Corporation Information
8.5.2 BGI Group Overview and Its Total Revenue
8.5.3 BGI Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 BGI Group Product Description
8.5.5 BGI Group Recent Development
8.6 Agilent Technologies
8.6.1 Agilent Technologies Corporation Information
8.6.2 Agilent Technologies Overview and Its Total Revenue
8.6.3 Agilent Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Agilent Technologies Product Description
8.6.5 Agilent Technologies Recent Development
8.7 QIAGEN
8.7.1 QIAGEN Corporation Information
8.7.2 QIAGEN Overview and Its Total Revenue
8.7.3 QIAGEN Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 QIAGEN Product Description
8.7.5 QIAGEN Recent Development
8.8 Macrogen
8.8.1 Macrogen Corporation Information
8.8.2 Macrogen Overview and Its Total Revenue
8.8.3 Macrogen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Macrogen Product Description
8.8.5 Macrogen Recent Development
8.9 ELITech Group
8.9.1 ELITech Group Corporation Information
8.9.2 ELITech Group Overview and Its Total Revenue
8.9.3 ELITech Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 ELITech Group Product Description
8.9.5 ELITech Group Recent Development
8.10 Analytik Jena
8.10.1 Analytik Jena Corporation Information
8.10.2 Analytik Jena Overview and Its Total Revenue
8.10.3 Analytik Jena Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Analytik Jena Product Description
8.10.5 Analytik Jena Recent Development
8.11 Bio-Rad
8.11.1 Bio-Rad Corporation Information
8.11.2 Bio-Rad Overview and Its Total Revenue
8.11.3 Bio-Rad Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Bio-Rad Product Description
8.11.5 Bio-Rad Recent Development
8.12 Promega
8.12.1 Promega Corporation Information
8.12.2 Promega Overview and Its Total Revenue
8.12.3 Promega Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Promega Product Description
8.12.5 Promega Recent Development
8.13 Texas BioGene
8.13.1 Texas BioGene Corporation Information
8.13.2 Texas BioGene Overview and Its Total Revenue
8.13.3 Texas BioGene Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Texas BioGene Product Description
8.13.5 Texas BioGene Recent Development
9 Production Forecasts by Regions
9.1 Global Top Molecular Diagnostic Instrument Regions Forecast by Revenue (2021-2026)
9.2 Global Top Molecular Diagnostic Instrument Regions Forecast by Production (2021-2026)
9.3 Key Molecular Diagnostic Instrument Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Molecular Diagnostic Instrument Consumption Forecast by Region
10.1 Global Molecular Diagnostic Instrument Consumption Forecast by Region (2021-2026)
10.2 North America Molecular Diagnostic Instrument Consumption Forecast by Region (2021-2026)
10.3 Europe Molecular Diagnostic Instrument Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Molecular Diagnostic Instrument Consumption Forecast by Region (2021-2026)
10.5 Latin America Molecular Diagnostic Instrument Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Molecular Diagnostic Instrument Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Molecular Diagnostic Instrument Sales Channels
11.2.2 Molecular Diagnostic Instrument Distributors
11.3 Molecular Diagnostic Instrument Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Molecular Diagnostic Instrument Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The Mobile Diagnostic Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Multi-vendor Instrument Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
Market Overview
The Asia Pacific Ambulance Equipment Market is poised for substantial growth from 2024 to 2034, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and advancements in medical technology. The market is projected to reach a valuation of US...
Market Overview
The Europe Ambulance Equipment Market is projected to experience substantial growth over the next decade, driven by advancements in medical technology, increasing healthcare expenditure, and the rising incidence of chronic diseases and medical emergencies. The market is ...
Market Overview
The North America Ambulance Equipment Market is expected to witness robust growth from 2024 to 2034, driven by the increasing incidence of medical emergencies, advancements in medical technologies, and the expanding healthcare infrastructure. By 2034, the market is proje...
Market Overview
The Global Ambulance Equipment Market is projected to experience significant growth over the next decade, driven by technological advancements, increasing incidence of chronic diseases, and a rising number of road accidents. The market, valued at USD XX.XX billion in 202...